fentanyl has been researched along with prazosin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Avery, BA; Behnke, M; Chear, NJ; Hiranita, T; Kamble, SH; León, F; McCurdy, CR; McMahon, LR; Obeng, S; Patel, A; Ramanathan, S; Reeves, ME; Restrepo, LF; Sharma, A | 1 |
| Sterz, H | 1 |
| Chan, SH; Lee, TY; Lui, PW | 2 |
| Chan, SH; Lee, TY; Lui, PW; Pan, JT; Tsou, MY | 1 |
| Wood, M | 1 |
| Doorley, BM; Sapru, HN; Willette, RN | 1 |
| Fujigaki, T; Makita, T; Nakamura, H; Shibata, O; Sumikawa, K; Tsujita, T | 1 |
| Bridges, MT; Grover, TE; Introna, RP; Pruett, JK; Yodlowski, EH | 1 |
| Chan, SH; Fu, MJ; Lee, TY; Lui, PW; Tsen, LY; Yeh, CP | 1 |
| Aypar, U; Erbengi, A; Erçelen, O; Sahin, A | 1 |
| Ding, X; McCune, DF; Murray, PA; Perez, DM; Sohn, JT | 1 |
2 review(s) available for fentanyl and prazosin
| Article | Year |
|---|---|
[New aspects in the treatment of acute cardiac insufficiency].
Topics: Adrenergic beta-Antagonists; Clonidine; Diazoxide; Digitalis Glycosides; Diuretics; Droperidol; Fentanyl; Fibrinolytic Agents; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Microcirculation; Myocardial Contraction; Neuroleptanalgesia; Nitroprusside; Phentolamine; Prazosin; Respiration, Artificial; Vascular Resistance; Vasodilator Agents | 1978 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Cardiac Surgical Procedures; Chlorpromazine; Dipyridamole; Disopyramide; Etidocaine; Female; Fentanyl; Half-Life; Humans; Imipramine; Kidney Diseases; Lidocaine; Liver; Mathematics; Meperidine; Methadone; Myocardial Infarction; Orosomucoid; Prazosin; Pregnancy; Propranolol; Protein Binding; Quinidine; Serum Albumin; Sex Factors | 1986 |
18 other study(ies) available for fentanyl and prazosin
| Article | Year |
|---|---|
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids.
Topics: Adrenergic Agents; Analgesics; Animals; Blood Proteins; CHO Cells; Cricetulus; Dopamine Agents; Guinea Pigs; Humans; Microsomes, Liver; Rats; Receptors, Adrenergic; Receptors, Opioid; Secologanin Tryptamine Alkaloids | 2020 |
Involvement of coerulospinal noradrenergic pathway in fentanyl-induced muscular rigidity in rats.
Topics: Adrenergic Fibers; Animals; Dose-Response Relationship, Drug; Fentanyl; Locus Coeruleus; Male; Microinjections; Muscle Rigidity; Prazosin; Rats; Rats, Inbred Strains; Spinal Cord; Yohimbine | 1990 |
Differential effects of prazosin and yohimbine on fentanyl-induced muscular rigidity in rats.
Topics: Animals; Blood Pressure; Electromyography; Fentanyl; Heart Rate; Male; Muscle Rigidity; Muscles; Prazosin; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1989 |
Involvement of locus coeruleus and noradrenergic neurotransmission in fentanyl-induced muscular rigidity in the rat.
Topics: Adrenergic alpha-Antagonists; Adrenergic Fibers; Anesthetics; Animals; Dose-Response Relationship, Drug; Efferent Pathways; Fentanyl; Locus Coeruleus; Male; Muscle Rigidity; Prazosin; Rats; Rats, Inbred Strains | 1989 |
Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioid-induced respiratory depression.
Topics: Analgesia; Animals; Atropine; Blood Pressure; Cholinergic Fibers; Dose-Response Relationship, Drug; Fentanyl; Heart Rate; Isoflurane; Male; Medulla Oblongata; Naloxone; Physostigmine; Prazosin; Rats; Respiration; Scopolamine | 1987 |
Effects of intravenous anesthetics on phosphatidylinositol turnover in rat cerebral cortical prisms.
Topics: Anesthetics, Intravenous; Animals; Cerebral Cortex; Diazepam; Dose-Response Relationship, Drug; Droperidol; Fentanyl; Flumazenil; Inositol Phosphates; Ketamine; Male; Naloxone; Norepinephrine; Phosphatidylinositols; Prazosin; Rats; Rats, Wistar; Thiamylal | 1994 |
Direct effects of fentanyl on canine coronary artery rings.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Intravenous; Animals; Arteries; Calcium Channel Blockers; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; Fentanyl; In Vitro Techniques; Indomethacin; Male; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Nifedipine; Prazosin; Propranolol; Vasoconstriction | 1995 |
Inhibition by intrathecal prazosin but not yohimbine of fentanyl-induced muscular rigidity in the rat.
Topics: Adrenergic alpha-Antagonists; Analgesics, Opioid; Animals; Electromyography; Fentanyl; Injections, Intravenous; Injections, Spinal; Locus Coeruleus; Male; Microinjections; Muscle Rigidity; Muscle, Skeletal; Prazosin; Rats; Rats, Sprague-Dawley; Yohimbine | 1995 |
Cerebral aneurysm surgery in a patient with phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Anesthetics, Inhalation; Anesthetics, Intravenous; Antihypertensive Agents; Blood Pressure; Cerebrovascular Circulation; Female; Fentanyl; Homeostasis; Humans; Intracranial Aneurysm; Isoflurane; Middle Aged; Nitroglycerin; Nitrous Oxide; Pheochromocytoma; Prazosin; Propofol; Propranolol; Vasodilator Agents | 1998 |
Fentanyl attenuates alpha1B-adrenoceptor-mediated pulmonary artery contraction.
Topics: Anesthetics, Intravenous; Animals; Clonidine; Dogs; Dose-Response Relationship, Drug; Fentanyl; Hydrogen-Ion Concentration; In Vitro Techniques; Phenylephrine; Piperazines; Prazosin; Pulmonary Artery; Receptors, Adrenergic, alpha-1; Vasoconstriction | 2005 |